Precision Optics (POCI) Q1 2027 Earnings Call Transcript

Source The Motley Fool
Logo of jester cap with thought bubble.

Image source: The Motley Fool.

DATE

Mon, Nov. 16, 2026

CALL PARTICIPANTS

  • Chief Executive Officer - Dr. Joe Forkey
  • Chief Financial Officer - Wayne Coll

TAKEAWAYS

  • Revenue -- $8.2 million, up 22% from $6.7 million in the prior-year first quarter.
  • Production Revenue -- $7.4 million, representing 23% growth driven by volume increases in systems manufacturing, the Micro-optics lab, and Ross Optical.
  • Net Loss -- $474,854, narrowing from a loss of $1,637,030 in the first quarter of the previous fiscal year.
  • Adjusted EBITDA -- A loss of approximately $224,000, compared to a loss of $1,228,000 in the prior-year period.
  • Gross Margin -- 22.5%, an increase from 14.2% in the prior-year quarter due to higher production volumes and manufacturing efficiencies.
  • Satellite Program Revenue -- $2.3 million, a sequential decrease of 39% reflecting a pullback in demand from a primary aerospace customer.
  • Satellite Program Outlook -- $1.2 million in revenue expected for the second quarter, with a recovery to $2 million per quarter in the third and fourth quarters.
  • Cystoscope Revenue -- $1.8 million, driven by improved throughput and yield on the single-use medical device line.
  • Ophthalmic Program Revenue -- $581,000, as shipments increased under an existing $3.5 million follow-on order.
  • Ross Optical Revenue -- $1.3 million, representing 26% year-over-year growth from $1.1 million.
  • Engineering Design Services Revenue -- $728,000, up 11% from $656,000 in the prior-year period.
  • Fiscal Year 2027 Revenue Guidance -- $30 million to $33 million, as management reiterated its full-year top-line targets.
  • Fiscal Year 2027 Adjusted EBITDA Guidance -- A loss of $1.2 million to $1.7 million, which the company maintained from its previous outlook.
  • Cash Balance -- $9 million at Sept. 30, 2026, compared to $9.8 million at June 30, 2026.
  • Total Bank Debt -- $1.1 million at the end of the quarter, including current maturities.
  • Micro-optics Lab Revenue -- $306,000, up from $100,000 in the prior-year quarter.
  • Operating Expenses -- $2.4 million, a decrease from $2.5 million a year ago.
  • New Production Transitions -- Two of four planned programs have transitioned to production, including a CMOS-based ureteroscope and a robotic surgery endoscope.
  • Defense Subassembly Order -- $1.3 million follow-on order from a large defense company with production commencing in the second quarter.
  • New Program Revenue Potential -- $1.5 million to $2 million combined annual run rate expected by fiscal year-end, with eventual scaling to $5 million to $6 million annually.
  • Second Satellite Customer Timeline -- Development is ongoing with production anticipated to begin in the fourth quarter of calendar 2028.
  • Sequential Margin Impact -- Gross margin declined from 25.3% in the fourth quarter of fiscal 2026, which had included a 3 percentage point benefit from a tariff-related credit.

Need a quote from a Motley Fool analyst? Email pr@fool.com

RISKS

  • Forkey stated, "We expect our second quarter to be the weakest of the year with a substantial adjusted EBITDA loss larger than the loss in the first quarter," which he attributed to the minimum point of the satellite demand pullback.
  • Forkey warned that while recent launch failures did not impact POC directly, grounding launch vehicles for a year or two "certainly would be a cause for concern" for the rate of satellite constellation setup.

SUMMARY

Precision Optics (NASDAQ:POCI) reported a 22% increase in year-over-year revenue and a significant narrowing of its net loss, supported by maturity in its single-use medical device production lines. Management reported that while a temporary demand pullback from a primary satellite customer will impact the second quarter, an early follow-on order provides a clear path to record quarterly revenue in the second half of fiscal 2027. The company maintained its full-year guidance and is focusing on transitioning four new development programs into production to drive long-term growth.

  • CEO Forkey stated, "The early satellite order gives us a clear path back to record quarterly revenue" by the second half of the fiscal year.
  • Management reported the restart of a rigid endoscope program for robotic surgery after two years of design and manufacturing process updates.
  • The company is evaluating new opportunities in computing and AI data centers where optical requirements are challenging to resolve.
  • Discussions have begun with a potential customer for a smaller optical communication terminal to be mounted on CubeSats.
  • Management indicated that newer development programs are being targeted for higher annual production potential of $3 million to $5 million.
  • The sales organization is being expanded following the appointment of Peter Thier as Senior Vice President of Sales and Marketing.

INDUSTRY GLOSSARY

  • CMOS: Complementary Metal-Oxide-Semiconductor, a technology used for high-performance imaging sensors in medical and industrial cameras.
  • CubeSats: A class of miniaturized satellites used for space research and communication constellations.
  • Cystoscope: An endoscope used specifically for the visual examination of the bladder.
  • Ureteroscope: A specialized medical instrument for examining the upper urinary tract and kidneys.
  • Arthroscopic: Relating to minimally invasive surgical procedures performed on joints using an endoscope.
  • Borescope: An optical tool used for visual inspection of narrow or inaccessible areas in industrial and aerospace applications.
  • Adjusted EBITDA: A non-GAAP measure of financial performance that excludes interest, taxes, depreciation, amortization, and stock-based compensation.

Full Conference Call Transcript

Operator: Good day, and welcome to the Precision Optics Reports First Quarter Fiscal Year 2027 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Robert Blum with Lytham Partners. Please go ahead.

Robert Blum: All right. Thank you very much, operator, and thank you to everyone joining the call today. As the operator mentioned, on today's call, we will discuss Precision Optics' First Quarter Fiscal Year 2027 Financial Results and is for the period ended September 30, 2026. With us on the call representing the company today is Dr. Joe Forkey, Precision Optics' Chief Executive Officer; and Wayne Coll, the company's Chief Financial Officer. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session. [Operator Instructions] Before we begin with prepared remarks, we submit for the record the following statement.

Statements made by the management team of Precision Optics during the course of this conference call may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results or strategies and are generally preceded by words such as may, future, plan or planned, will or should, expected, anticipates, draft, eventually or projected.

Listeners are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in the company's filings with the Securities and Exchange Commission. All forward-looking statements contained during this conference call speak only of the date in which they are made and are based on management's assumptions and estimates as of such date.

The company does not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise. With that said, let me turn the call over to Dr. Joe Forkey, Chief Executive Officer of Precision Optics. Joe, please proceed.

Joseph Forkey: Thank you, Robert, and thank you all for joining our call today. Revenue in our first quarter of fiscal 2027 was $8.2 million. That was down from the record $8.8 million in the previous quarter, but up 22% from a year ago. As we've discussed on previous calls, we expected a slowdown in orders from our existing satellite customer, and we are seeing that in effect. We have positive news regarding that customer that I will elaborate on in just a minute. Even with fewer satellite subassembly shipments than in the previous quarter, we still sustained much of the increase in production we achieved last year.

Manufacturing overall came in ahead of our internal expectations, including a stronger contribution from our micro-optics lab. We also did better than we expected on adjusted EBITDA. We had a loss of approximately $200,000 compared to a loss of $1.2 million a year ago. Higher production volumes and the work our COO, Joe Traut, and his team have done to improve manufacturing efficiency, both contributed to that improvement. The reduction in satellite subassembly shipments impacted the first quarter and will further impact the second quarter. As we reported just a couple of weeks ago, this customer has now placed the next follow-on order much sooner than previously expected.

We still anticipate the slowdown in satellite subassembly shipments to significantly affect our December quarter, but we expect revenue on this program to recover in Q3 and Q4. In the meantime, we will continue to grow with other customers so that the overall top line should be meaningfully higher when our satellite customer returns to its normal demand. In the first quarter, we started production on a urology product. And just this month, we restarted production of an endoscope used in robotic surgery. These are the first 2 of 4 development programs we expect will transfer to production this fiscal year and contribute to production revenue in the second half.

Most importantly, as we look out beyond Q2 to the end of this fiscal year and the beginning of fiscal 2028, we expect quarterly revenue to again reach new record highs. These revenue levels will be supported by a base of existing satellite subassembly and single-use endoscope production, along with steady Ross Optical revenue, augmented by a recovery in our micro-optics defense business by the 4 programs transitioning to production and by an increase in our product development engineering work supported by recent updates in our sales organization. In addition, the opportunity represented by our new second satellite subassembly program has the potential to further drive growth to even higher levels by the middle of fiscal 2028.

On our call today, I'll focus my comments primarily on 3 topics: First, a business update, including the major programs behind the first quarter results along with those transitioning to production; second, a brief overview of updates in our sales and marketing activities and some broad market observations. And finally, I'll put those developments in the context of our outlook for fiscal 2027. As we discussed on our last call, our satellite customer has pulled back on demand for our optical communications subassembly. First quarter revenue for this program was $2.3 million, a quarter-over-quarter decrease of 39%.

With projected revenue of only $1.2 million, we expect the second quarter will be the minimum of the dip caused by this customer's pullback. Our customer has now issued a follow-on order and shared with us their downstream build and launch plans, which support anticipated production levels of approximately $2 million for each of Q3 and Q4. An update to the product design is anticipated for fiscal 2028, but with transition planning already begun, we expect quarterly production and revenue levels to remain similar or slightly higher in fiscal 2028. We have also begun discussions for POCs to take over production of additional optical subassemblies for this program.

While these discussions are still very early stage, they could represent a substantial increase in revenue from this customer if they are successful. In late September, we received a follow-on engineering order from our second satellite communications customer, a U.S.-based technology company developing a new satellite communications constellation. Over the last 2 months, POC's technical team working closely with our customers' team has completed a first round prototype design in record time, on schedule and within budget. Our customer has expressed complete satisfaction with this work. This program continues to move forward with urgency, driven by our customers' desire to get through prototype builds, design updates and production launch as quickly as possible.

Our customer has repeatedly expressed a need to ensure that the final design be well aligned with POC's manufacturing capabilities, supporting their expressed intent to have POC manufacture the product once development is complete. This customer now anticipates production to begin about a year from now in the fourth quarter of calendar 2028. Turning to single-use medical devices. Our cystoscope program generated approximately $1.8 million in production revenue in the quarter, driven by ongoing improvements in throughput and yield. Over the last several quarters, we've reached a point where we can plan and forecast performance of this production line with considerably more confidence than we could a year ago, another great indicator of the maturity of our production operations.

On our single-use ophthalmic program, we generated $581,000 of revenue in Q1 as shipments increased under the existing $3.5 million order. Based on the experience we gained with the single-use cystoscope product, we've been able to bring the single-use ophthalmic line up to volume more quickly and efficiently, achieving better throughput, yields and margin earlier in the life of the program. As this production line continues to mature, we expect revenue to increase, particularly in the second half of this fiscal year. In the first quarter, we started production of a CMOS-based optical subassembly for a ureteroscope that has been in our product development pipeline for a few years.

And just a couple of weeks ago, we restarted production of a rigid endoscope with an articulating tip used for robotic surgery after roughly 2 years of design and manufacturing process updates. We expect this program to begin contributing production revenue in the second quarter. These are 2 of the programs we have been anticipating but transitioned from product development to production this year. We have 2 additional programs that we expect to move into production over the next 6 to 9 months, a micro endoscope for an arthroscopic application and a high-end borescope for aerospace applications. For all 3 of these programs transferring to production, initial volumes will be typically modest, and we expect them to build over time.

By the end of this fiscal year, we expect these programs combined will be at an annual run rate of $1.5 million to $2 million per year and that they will eventually grow to contribute approximately $5 million to $6 million annually. In our micro-optics lab, we started production during the second quarter on the $1.3 million follow-on order that we discussed on our last call for the subassembly used in a defense application. We have manufactured this product for many years and therefore, expect good margins and predictability. And with the introduction of additional sales resources, we are beginning to see additional programs come into the micro-optics lab pipeline.

Finally, revenue from our Ross Optical division for the first quarter was $1.3 million, down from the previous quarter by 10%, but up year-over-year by 26%. We anticipate Ross revenue to continue at this level for the remainder of fiscal 2027. On our last few calls, we have highlighted the need to reinvigorate our product development pipeline. This part of our business is a profit center itself, but more importantly, it develops the programs that ultimately feed our production business, which drives long-term growth. As we discussed on our last call, Peter Thier joined us about 2 months ago as Senior Vice President of Sales and Marketing.

He is moving aggressively to improve and augment our sales process and team, and I'm confident that with his leadership, we will quickly improve our product development pipeline. While there is no sign of limitations to our existing medical device and satellite communication markets, we are seeing new opportunities in various areas, including extensions of these markets and new markets altogether. Trends in computing and AI, for example, are bumping up against requirements in the optical space that are challenging to resolve, which is precisely where Precision Optics can offer the greatest value. Whereas historically, we have maintained our focus on medical devices, the magnitude of the opportunities has caught our attention.

We are spending more time evaluating these opportunities and expect to elaborate further on upcoming earnings calls. Given our recent success in laser-based satellite communication systems, this will continue to be a market we focus on and is the first major expansion in our outward directed sales and marketing activities beyond medical device. For all the reasons we discussed in our last call just 6 weeks ago, we believe the opportunities here are substantial. The programs we support today are focused on building out the space communications backbone with large satellite constellations.

One of the areas we talked about on our last call was the expectation that eventually, our work could expand from supporting the large constellations to supporting the systems that will go on individual ground, air or space vehicles that communicate to the constellation backbone. Just last week, we began discussions with a potential customer who wants our help developing a smaller-sized optical communication terminal that can be mounted on Sat Cubes (sic) [ CubeSats]. These are small satellites about the size of a breadbox. This is exactly the, kind of, development we anticipated and discussed on our last call, and it's great to see opportunities like this starting to develop already.

In September, the biggest open question in our forecasting was when we would see another order from our established satellite customer, which we now have received. At the same time, the production timetable for our second satellite customer has moved into fiscal 2028. Net-net, these 2 developments nearly cancel each other out, except that with the new order in hand from our existing customer and greater backlog, we have better clarity on the rest of the year. We expect our second quarter to be the weakest of the year with a substantial adjusted EBITDA loss larger than the loss in the first quarter.

However, the early satellite order gives us a clear path back to record quarterly revenue, further supported by the ramp in volume of the programs newly transferred to production and by growth in product development as new programs we are pursuing now come into the pipeline. Today, we are reiterating the guidance we provided in September for fiscal 2027 revenue of $30 million to $33 million and an adjusted EBITDA loss of $1.2 million to $1.7 million.

With growth recovering in the second half of the fiscal year and with our second satellite subassembly customer anticipating new record levels of production for POC in the first half of fiscal 2028, the long-term growth potential of POC is as strong as it has ever been. I'll now turn the call over to Wayne for a more detailed review of the quarter.

Wayne Coll: Thank you, Joe. I'll review our results for the quarter ended September 30, 2026, and I'll compare them primarily with the same quarter last year and give some details on the changes from that quarter. First quarter revenue was $8.2 million compared to $6.7 million a year ago, an increase of approximately $1.5 million or 22%. Revenue was down from the record $8.8 million in the fourth quarter of fiscal 2026, reflecting the reduction in satellite shipments Joe has discussed. Production revenue was $7.4 million compared to $6.0 million in the prior year quarter, an increase of 23%. Production includes systems manufacturing, the Micro-optics lab and Ross Optical. All 3 businesses grew compared with the prior year quarter.

Systems manufacturing, the largest of the 3, increased by approximately -- to approximately $5.8 million from $4.9 million. Micro-optics lab revenue increased to approximately $306,000 from $100,000 and Ross Optical increased to approximately $1.3 million from $1.1 million. Engineering design services revenue was $728,000 compared to $656,000 in the first quarter last year, an increase of 11%. Gross profit was approximately $1.8 million, up $946,000 a year ago. Gross margin increased to 22.5% from 14.2%, an improvement of more than 8 percentage points, which was supported by substantially higher production volume together with better manufacturing efficiencies. Sequentially, gross margin declined from 25.3% in the fourth quarter of fiscal 2026.

As we explained on the last call, that quarter included a tariff-related benefit that added roughly 3 percentage points to reported gross margin. That benefit makes the sequential comparison less straightforward. The year-over-year comparison is a better indicator of the progress we've made as our production business has grown. Operating expenses were approximately $2.4 million compared to $2.5 million in the first quarter of the prior year. Selling, general and administrative expenses declined to approximately $2.05 million from $2.23 million. Research and development expenses were approximately $306,000 compared to $312,000 a year ago. The combination of higher gross profit and lower operating expenses reduced our operating loss to $518,000 from approximately $1.6 million last year.

Most of that improvement came from the increase in gross profit. Our net loss narrowed to approximately $475,000 or $0.04 per share compared to a loss of $1.6 million or $0.21 per share a year ago. In the current quarter, we earned approximately $74,000 of interest income and incurred approximately $30,000 of interest expense. Adjusted EBITDA was a loss of approximately $200,000 in the quarter, improving by $1 million over the loss of approximately $1.2 million a year ago. In the fourth quarter of fiscal 2026, adjusted EBITDA was positive $355,000. Noting that adjusted EBITDA is a non-GAAP measure, our earnings release provides a reconciliation to the GAAP net loss.

We ended September with approximately $9 million in cash and cash equivalents compared to $9.8 million at June 30, and total bank debt, including current maturities, was approximately $1.1 million at September 30. As Joe mentioned, we are leaving our guidance for fiscal 2027 unchanged from the guidance we gave in our September call. We expect Q2 to be the most challenging quarter given the revenue delay but expect a strong recovery in the second half. I'll now turn the call back to Joe for some final comments.

Joseph Forkey: Thank you, Wayne. Let me finish by summarizing a few points. Our first quarter revenue and adjusted EBITDA were both down compared to the previous quarter. However, compared to a year ago, both improved dramatically. Much of that improvement reflects the investments we've made to build the team and operational infrastructure needed to support higher production levels with greater efficiency and throughput. The pullback in our satellite subassembly program will continue to affect near-term results, but we see a clear recovery beginning in the third quarter and expect our growth trajectory to strengthen in the latter part of the year.

With the infrastructure largely in place, our focus now is on growing our product development pipeline and ultimately driving higher production levels. With 4 programs expected to transition to production this year and expanding sales and marketing organization, and significant opportunities in medical device, satellite communications and new adjacent markets, we believe POC is well positioned for significant long-term growth. I'd like to thank our employees for the work behind these results and all of you for your continued support. At this time, we'd be happy to take any questions.

Operator: [Operator Instructions] The first question will come from Alex Fuhrman with Lucid Capital Markets.

Alex Fuhrman: Congratulations on a really nice quarter compared to last year. It looks like your 2 single-use endoscope programs that are in production here were almost 1/3 of your revenue for the quarter. Can you talk a little bit about how much you expect those 2 programs to contribute going forward on an annual basis? And then it sounds like there's a few more endoscope programs behind that, that are expected to go into production. How much do you expect that to kind of represent on an annualized basis this time next year?

Joseph Forkey: Yes. Thanks, Alex. Nice to hear from you. Thanks for the question. So with regard to the 2 programs that we already have in production, the 2 single-use endoscopes, the -- both of those lines are running pretty well now. Anyone who's been following us for a while knows that the first one took a little while for us to get up and running over the last couple of years. But we made all the right investments and things are running much smoother now. The first of those programs, the single-use cystoscope has gotten to a point where it's leveled off a little bit.

Exactly where it goes in the future will depend on how successful our customer is in pushing this further into the market. But I think they're having some good success. We've talked on earlier calls about the fact that they have a line set up now, which we always anticipated, and that we're receiving royalties now for units that they are producing. So the actual, sort of, revenue level from that program will depend both on how quickly the market accepts this new product, which is a follow-on from their existing product. And also, it will depend on how much we continue manufacturing and how much we receive royalties.

And that's a question that we'll continue to look at with our customer. Either way, we expect to have similar contribution to the bottom line. But in terms of the absolute quantities and revenue level from that program, it will depend on how that develops. For the second program, the ophthalmic product is really still just ramping. And that customer is just getting into production now. So the last couple of quarters we saw about $0.5 million a quarter in revenue. That one very easily could double in the next couple of quarters. And those are the kinds of increases we see for that program moving into the future.

One of the programs that we see going into production, the micro arthroscope is actually also a single-use product, but the volumes there, we expect will be more limited. That program will go into production at about $100,000 a quarter or so and then could double or even triple from that level as we go through the next year or so. So in terms of the answer to your, the second part of your question, Alex, where do we see this a year from now? Certainly, 2 of these programs will grow in terms of revenue. We think all 3 will grow in terms of the bottom line, again, depending on royalties versus revenue.

And then we see new programs coming in as well. I think today, we're probably somewhere around 50% or 60% medical device. I think probably in the next year, we'll see that in a pretty similar level. If and when the second satellite program goes into production a year from now, I think that will increase the top line by a significant amount. So percentage-wise, the medical may be less, but I think it will continue to grow as we've seen in recent quarters.

Robert Blum: Okay. That's really helpful. And then gross margin in the quarter was pretty nice, up more than 800 basis points year-over-year. Can you help us kind of understand how the changes in your revenue mix are impacting gross margin. I imagine the satellite piece being smaller this year and presumably bigger next year. Can you help us understand what kind of an impact that has on your gross margin? And just with some of these endoscope programs progressing into production, should we expect to continue to see gross margin rise over the next couple of years?

Wayne Coll: I think that's correct, Alex. And what we saw this quarter was a return to really good production levels for the Micro-optics laboratory. That one was very low, if not negative margin last year based on the revenue levels. So that's certainly been contributing. We've seen a strong pickup or kind of consistency coming out of the Ross Optical group, and that's been a very strong contributor to gross margins. We've seen improvements in product development and improved utilization of our engineering resources. that's also contributing. So the mix is, things are pointing up pretty positive in other areas of the business.

And I think the main change that we'll see is the satellite demand, as we've talked about, is going to impact the margin in the second quarter. The other indicators point up, but it impacts the margin in the second quarter, and that's what will drive margin improvement in the remainder of the year as we get back into full production.

Operator: [Operator Instructions] All right.

Robert Blum: Operator, while we wait to see if there's any questions through the live teleconference line, we have a couple of questions through the webcast portal here, Joe and Wayne. The first here, and you touched on this a bit, but maybe to expand, how many products are in development? We had 9 last call. And how many will enter production this fiscal year? And what are the most important to revenue? And can you talk about revenue estimates for these products? So I know you touched on this, but maybe just to expand there slightly.

Joseph Forkey: Yes, sure. So the answer to the first part is, so I'll say it this way. All 9 of the programs that were in the product development pipeline are still in our forecast going forward. Two of those have now moved to production. So that would bring the number in product development down to 7. But in the meantime, we have another one that's gone into the product development pipeline. This is a new customer that we're working with on a gastrointestinal scope. So that one is just getting started. That will show up on the product development pipeline slide when we update it for this quarter.

We have a number of other programs, a number of other customers that we're talking to about additional pipeline programs. So I wouldn't be surprised if we see a couple more come in, in the next couple of quarters. I'll also just add that we've talked about updating our sales and marketing team with Peter Thier coming on. There are a number of programs that are in our product development pipeline that have been there for quite some time. Some of them we, sort of, inherited from the Lighthouse acquisition now 5 or 6 years ago.

Some of these are going into production with revenue levels that are a little lower than we would anticipate for some of the new programs. I used to say 3 or 4 years ago, we were looking for programs that would be $1 million a year. Now we're really looking for programs that will get to $3 million, $4 million, $5 million a year. And that's part of what the sales and marketing team is looking at. We have enough opportunities now that we can be a little bit choosy, picky and choosy.

And so I expect with some of the new programs that are coming in, we're going to see those in the long run, contribute more to the production when they go into production. And I think they'll get to production a little bit faster because we've also been updating our engineering and technical team as well in order to be able to move things through the product development pipeline faster. To the second part of the question, I gave some numbers in the prepared remarks about the 4 programs that are moving to production. I sort of lump them all together. I guess I can call out the ones that we expect to have the largest impact.

In the long run, all of these, we expect will be at the $1 million level or so because that's what we were targeting previously, as I mentioned. The endoscope for the robotic surgery procedure could very easily get to $2 million or $3 million and be one of the higher contributors. The arthroscope product, the microarthroscope, I think, could probably get to about $2 million. The other 2 probably when they mature in production will be at the $1 million level.

Robert Blum: [Operator Instructions] The next question here is, how should we think about POC's addressable markets for the satellite laser communications market? How many constellation companies are there? And what size are they compared to your current customers?

Joseph Forkey: Yes. So the first thing I'll say is that this market is still developing fast. And one of the comments I made during the prepared remarks was really meant to sort of emphasize that. So let me answer the specific question, then I'll come back to what I was trying to get at in the remarks. So in terms of the large satellite constellation companies, there's one really big one everyone knows about, that's SpaceX. And SpaceX is known for doing everything internally. And I think that's very likely the case for a lot of their optics. We know a bit about that.

Beyond that, there's another 4 or 5, there's another handful of companies that are building satellite constellations that are, say, 1,000 satellites or more. right, not including things that are happening in China, where we would not be able to engage. So we already have 2 of those 3 or 4. So there may be a couple of others that could be similar size in terms of the standup of the constellations, if you like.

The other point I want to make, and we've talked about this a lot in the last earnings call, but these constellations, once they get up and running, because the satellites are in lower Earth orbit, they don't stay in orbit perpetually after some 3, 4, 5, 6 years, the orbit decays and they come back into the atmosphere. And in fact, they're required to turn them around and send them into the atmosphere, so they burn up and don't become space junk. So the customers that we have today and the other large constellation customers will have a need to renew the products or the satellites that are in their constellation.

So these are really, sort of, evergreen in terms of the business that we have with these particular customers. The other thing I would point out is that we've talked again today about the fact that there are additional optical subassemblies that are used in these constellations -- used on these satellites even beyond the particular assembly that we're building today. And we now have -- having gone through an exercise for one of our customers who asked us to look at a significant number of the other optical subassemblies.

We have a good understanding that the size of the market for each one of these customers could be as much as 4x or 5x as large as the customer that we've been delivering product to already. So again, there's probably 4 or 5 customers in this category. We already are working with 2 of them. Each one of them at minimum would be similar to the customer that we've already been working with and could be as much as 4x or 5x that size. More generally, though, I think it's important to recognize that the optical systems that we're making for these customers who are putting up satellite constellations are going into their optical communications terminal.

And those optical communication terminals in the long run are going to be required for anything that's communicating to that satellite constellation from the ground or from the air or from space. And so I made the point in this -- in our comments today that we're already talking to one customer about building those kinds of systems for so-called Sat Cubes (sic) [ CubeSats ]. So these are other individual satellites that will be communicating to the satellite backbone. But we fully expect those kinds of terminals to extend to airplanes into ground vehicles and all the other places where this backbone is ultimately going to be used.

Today, it's really only being used by consumers who are using RF antennas to communicate to that backbone. But over the long run, we expect that there's going to be a market for basically any vehicle that's going to want to communicate with that satellite network. And the size of that part of the market is still difficult to predict and difficult to understand, and it's just starting to grow. We were pretty excited that we already have found a customer who's interested in working with us on that terminal that's going to be part of that system, which is then communicating to the backbone. So there's many parts to this market.

The pieces that we're working on today are these 3 or 4 constellation builders. But the way I see it is POC is in a great position having worked with these big guys to set up the backbone, we're going to be in a great position to work with all the other companies that are going to want to build optical communication terminals for all the vehicles that are then going to be communicating to this backbone. So I think there's plenty of opportunity here for many, many years to come.

Robert Blum: All right. Very good. Thank you. Operator, I'm going to turn it back over to you for any additional questions through the live teleconference line.

Operator: We do have a question from [ Chris Machovsky ], private investor.

Unknown Analyst: Congratulations on the much better-than-expected results. I have a question about the satellite business. We had some news about an exploding rocket. I'm not asking you to name any clients, but with, kind of, explosions and lost satellites, is that good for your business? Is that bad for your business? Is that something that investors should worry about?

Joseph Forkey: Yes. Thanks, Chris. Thanks for the question and for the comments. So I guess what I would say without commenting specifically on specific customers, the satellites that were lost in the explosion, in this case, I think it wasn't an explosion. It ended up not getting to the right orbit and cracking back down to earth or burning up in the atmosphere. But the number of satellites that was on that rocket, I think it was 40 satellites compared to the total numbers that these big satellite constellation companies are building, that's a small number, right?

So from that standpoint, it's not going to make or break any of the companies that are doing this nor anyone like us who is working on the subassemblies that go into it. It may mean that there's another 40 satellites that have to be built. So from that standpoint, I suppose whoever is doing the optics would have some extra orders. The more important piece, though, is that to the extent that this grounds that launch vehicle system, the ULA system for some period of time, it could slow down the rate at which the constellations are set up. There are a limited number of launch vehicles.

And if you look at how these constellation developers are using them, other than SpaceX who uses their own rocket, all the rest of them are reliant on these 4 or 5 or 6 other rocket platforms. So to the extent that this slows things down, that could have a negative effect on the rate at which the satellites get launched. Now again, if you look at this launch vehicle, the Blue Origin challenges that they had back at the beginning of this year slowed things down as well.

On the flip side, there was enormous pressure both from the commercial side of things, but almost more importantly, from the defense community and from the government side of things to get these programs running smoothly as fast as possible. So I guess the short answer is it's not good for anyone, any of us who are working on satellite programs. It could be a delay from one of the launch vehicles as they figure out what's going on with the systems. But there is enormous incentive for them to get it sorted quickly. And given the fact that to launch the full complement of satellites into a constellation, is scheduled to run out many years, 2, 3, 4 years.

If they're shut down for a few months in order to figure out what happened, it's probably not a big deal. If they're grounded for a year or 2, that certainly would be a cause for concern.

Unknown Analyst: Okay. That's very useful. So another question about your previous comments about the possibility that to use your devices in communications with other vehicles. I think the way I understand it, in space, you get the advantage that lasers are very useful because there's no air, so the light propagates far. Would lasers work for communication from satellites to airplanes?

Joseph Forkey: Yes, it's a great question, Chris. So you're exactly right that in space, you don't have to worry about the air. You don't have to worry about cloud. You don't have to worry about rain and snow and all the rest of it. So that makes space the ideal place to communicate with optical communication or laser communication. It also makes it the ideal place to start developing these systems that are used for laser communication. The benefits of laser over RF in terms of the amount of power that's required in terms of the security of the communication because it's directed and not as -- the signal is not spread out as far.

And so it's harder to spy on, if you like. And also, perhaps most importantly, the increased bandwidth you can get from laser provides large incentives for people to figure out how to use lasers to communicate from satellite to airplanes, as you suggested or even to the ground and vice versa. The challenges are exactly what you alluded to, going through air makes it more challenging. If you have clear dry air, you can certainly communicate with the laser from the ground or from an airplane up to a satellite and vice versa. The challenge becomes when you have particles in the air, when you have clouds in the air or other things that are difficult to get through.

And when you have to deal with -- even if you can get all the energy through the atmosphere, you still have to deal with the fact that the atmosphere will change the direction of the laser because there will be density gradients and all kinds of other things. So there are ways to solve those problems in terms of dealing with the density gradients. It has to do with adaptive optics, and there are people who are working on those aspects of the systems, the adaptive optic pieces of them. The science behind it is well known, but we have to get it into a size and shape and cost profile that makes it useful.

And as that happens, the particular pieces that we make, the subassemblies with a very high precise alignment are going to be required elements for those systems. The second piece, which is the difficulty of clouds and particles in the air, those are more challenging to deal with. And so what's likely to happen is that you may end up with systems where the plane will have a primary communication source, which is a laser source so that if you're above the cloud, you don't have to worry about that and it uses adaptive optics to get through the atmosphere.

And then when you go below the cloud, it will have an RF signal antenna that it uses for sort of a backup at lower bandwidth and requiring higher power. So all of that is to say, communicating satellite to satellite is the easiest way to use lasers. There are ways to use lasers to get to the ground or to get to aircraft. And I think we're going to start to see those things develop as we move forward. And again, the pieces that we're making, I think, will be well suited to go into those systems as well.

Unknown Analyst: Okay. So a couple of more questions on that. First, does that make the market much, much larger because it seems that there's like at least thousands of clients per satellite. And secondly, are you already getting development projects on that kind of work if you allow to [talk]?

Joseph Forkey: Yes. So I do believe that the market could get much larger because you're right, there will be many vehicles communicating with each satellite. On the other hand, it will be much more disjointed because you're going to have many more companies that are making the vehicles. So we'll have to see how we engage with a much more fragmented market, I guess, and we'll see that as it goes. The first customer that we're talking to that would be working on the vehicles is the one that I referenced earlier, which is the Sat [indiscernible] sorry, is the -- yes, the CubeSat company that's making one of these devices to sit on satellites.

So again, that one is a vehicle, but it has the benefit of being up in the space. So we're not working with customers, any customers now that are working on these kinds of systems, the optical communication terminals for aircraft or for ground vehicles. But that certainly is part of the market that we're looking at, and we're trying to figure out who's doing what in that area, and we'll pursue that aggressively.

Unknown Analyst: Okay. And one more question for the more near future. Is there an upside to annual revenue guide and would that be just if there's like more use on the endoscopes and they required to buy more? Or do you think that the orders are already pretty much set?

Joseph Forkey: We have pretty good visibility into what, kind of, endoscope orders we expect to see over the next couple of quarters and for that matter, orders from much of the rest of the business. We have given a range in terms of our guidance, and that range has to do with the variability in what we see coming from the various customers and how they all stack up and what the exact timing is. So we feel pretty good about the range that we've guided to.

And so I think your question I guess what I would say is the high side of that range is where we would end up if we end up with the high side of the endoscope orders and other things.

Robert Blum: All right, Joe, we have one additional question here from the webcast portal. Have there been more talks on the AI data center front since the last call? Are companies reaching out to you or vice versa?

Joseph Forkey: The short answer is we have not been in direct contact with any companies who are working on AI data centers. I think, frankly, they're sorting out the sort of the initial stages of understanding whether that's going to work or not. I think they already know that there are capabilities for doing satellite to satellite communication. And so they haven't been seeking us out, and we haven't found them yet. But it's certainly -- again, it's another place where I think this market is -- has the potential to develop and become much larger, and we're going to continue to watch that and when the time is right, engage with the right people.

Robert Blum: All right. Very good. Well, I am showing no further questions here, Joe. So I will turn it back over to you for any closing remarks.

Joseph Forkey: Thanks, Robert, and thank you to everyone who joined us today. We look forward to updating you again in a couple of months. Thanks, everyone. Have a good night.

Operator: The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.

Should you buy stock in Precision Optics right now?

Before you buy stock in Precision Optics, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Precision Optics wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $322,605!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $927,581!*

Now, it’s worth noting Stock Advisor’s total average return is 792% — a market-crushing outperformance compared to 202% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of November 19, 2026.

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. Parts of this article were created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold Price Forecast: XAU/USD regains ground below $3,700, outlook remains fragileGold price (XAU/USD) attracts some bids after hitting a fresh yearly low at $3,693.50 on Thursday. In the European trade, the Gold price is 0.42% higher to near $3,740.
Author  FXStreet
8 hours ago
Gold price (XAU/USD) attracts some bids after hitting a fresh yearly low at $3,693.50 on Thursday. In the European trade, the Gold price is 0.42% higher to near $3,740.
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 19, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 19, 2026. Read on for the details.
Author  Mitrade
13 hours ago
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 19, 2026. Read on for the details.
placeholder
Australian Dollar falls below 0.6700 as Unemployment Rate jumps to the highest level in five yearsThe AUD/USD pair tumbles to its lowest since January around 0.6695 during the early Asian session on Thursday. The Australian Dollar (AUD) faces some selling pressure against the US Dollar (USD) following weaker-than-expected Australian employment data.
Author  FXStreet
15 hours ago
The AUD/USD pair tumbles to its lowest since January around 0.6695 during the early Asian session on Thursday. The Australian Dollar (AUD) faces some selling pressure against the US Dollar (USD) following weaker-than-expected Australian employment data.
placeholder
US Dollar Index Price Forecast: DXY could target 104.00 as bulls await FOMC MinutesThe US Dollar Index (DXY), which tracks the Greenback against a basket of currencies, regains positive traction following the previous day's brief pause, retesting its highest level since April 2025 during the first half of the European session on Wednesday.
Author  FXStreet
Yesterday 10: 14
The US Dollar Index (DXY), which tracks the Greenback against a basket of currencies, regains positive traction following the previous day's brief pause, retesting its highest level since April 2025 during the first half of the European session on Wednesday.
placeholder
Gold Hits Near 1.5-Year Low Below $3,800 as Bears Threaten Drop to $3,500Gold prices broke below the $3,800 threshold to hit a new low since September 2025, warranting heightened vigilance over downside risk toward $3,500.On November 18, international spot gol
Author  TradingKey
Yesterday 08: 35
Gold prices broke below the $3,800 threshold to hit a new low since September 2025, warranting heightened vigilance over downside risk toward $3,500.On November 18, international spot gol
goTop
quote